Coya Therapeutics, Inc. Common Stock
COYA
COYA: Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
moreShow COYA Financials
Recent trades of COYA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by COYA's directors and management
Government lobbying spending instances
-
$10,000 Jul 19, 2022 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$10,000 Apr 19, 2022 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
New patents grants
Federal grants, loans, and purchases
Followers on COYA's company Twitter account
Number of mentions of COYA in WallStreetBets Daily Discussion
Recent insights relating to COYA
Recent picks made for COYA stock on CNBC
ETFs with the largest estimated holdings in COYA
Flights by private jets registered to COYA